Bernhard Liebl
Papers
2
Total Citations
8
H-Index
2
About
Bernhard Liebl is a researcher whose work has focused on the intersection of clinical pharmacology, biochemical methodology, and receptor biology. His contributions center on the development and refinement of automated laboratory techniques for radioligand binding assays, with particular application to the study of adrenoceptor pharmacology in human biological systems. Liebl's most recognized work involves the creation of partially automated radioligand binding assay systems that leverage robotic sample processors and personal computing technology to enhance the precision, throughput, and reproducibility of equilibrium binding studies. These methodological innovations were applied in clinically meaningful investigations, including the characterization of circadian variation in β₂-adrenoceptor sites on peripheral mononuclear leucocytes — research with implications for chronobiology and cardiovascular pharmacology. By streamlining complex binding experiments to handle up to 16 simultaneous saturation or competition studies, Liebl helped bridge the gap between basic receptor science and practical clinical and pharmaceutical research applications. Though his citation counts remain modest, his technical contributions represent meaningful advances in laboratory automation during a formative period for receptor pharmacology methodology in the early 1990s.
Research Focus
Key Achievements
Top Papers
- 1
- 2